Journal
CHEMBIOCHEM
Volume 10, Issue 6, Pages 994-998Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.200800803
Keywords
antitumor agents; beta-peptides; hDM2; inhibitors; p53; protein-protein interactions
Funding
- Novartis Institutes for Biomedical Research Vienna
- Medical Research Council [MC_G0802522] Funding Source: researchfish
- MRC [MC_G0802522] Funding Source: UKRI